Clinical Trial Update: Use of Dalfampridine in Primary Lateral Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update shows that dalfampridine is being studied for primary lateral sclerosis and is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lateral Sclerosis

Drugs mentioned

• Ampyra (4-aminopyridine)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Motor Neuron Disease, Upper | Phase 1 | Status: ACTIVE_NOT_RECRUITING